Why the study?
Does exogenous growth hormone administration increase serum insulin-like growth factor I (IGF-I) and related markers in healthy adults?
Does exogenous growth hormone administration increase serum insulin-like growth factor I (IGF-I) and related markers in healthy adults?
Exogenous growth hormone administration elicits a more robust increase in IGF-I in men compared to women, making IGF-I the most specific marker for detecting supraphysiological GH exposure.
No takes yet. Share an insight, caveat, or question.
Sex-specific IGF-I monitoring is warranted during GH therapy; extends validation of IGF-I as the primary marker for supraphysiological exposure.
Dall et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: